Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas. [electronic resource]
Producer: 20061127Description: 1546-57 p. digitalISSN:- 1460-2105
- Animals
- Antineoplastic Agents -- administration & dosage
- Blotting, Western
- Brain Neoplasms -- drug therapy
- Cell Line, Tumor
- Disease Models, Animal
- Fluorescent Dyes
- Gene Expression Regulation, Neoplastic
- Glial Fibrillary Acidic Protein -- metabolism
- Glioma -- drug therapy
- Humans
- Immunohistochemistry
- In Situ Nick-End Labeling
- Injections, Intravenous
- Luminescent Proteins
- Mice
- Mice, Nude
- Oncolytic Virotherapy -- methods
- Recombinant Proteins -- administration & dosage
- Research Design
- Rhabdoviridae Infections -- virology
- Transfection
- Tumor Cells, Cultured
- Viral Matrix Proteins -- administration & dosage
- Red Fluorescent Protein
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.